RA Capital Healthcare Fund LP's Form 4 filing
DICE Therapeutics, Inc. (DICE) · filed Mar 27, 2023
- Accession no.
- 0001104659-23-037172
- Filed
- Mar 27, 2023, 5:01 PM ET
- Trade date
- Mar 23-27, 2023
- Filing delay
- 4 days
- Rule 10b5-1 plan
- Not checked
This filing lists 3 non-derivative transactions and 0 derivative transactions. Open-market purchases total $13.5M. It was filed 4 days after the trade.
Reporting owners
A Form 4 can have several reporting owners, such as a person and a fund they control. Trade tables show the first one.
| Owner | Relationship to the company |
|---|---|
| RA Capital Healthcare Fund LPCIK 0001315082 | Director, 10% Owner |
| Ra Capital Management, L.P.CIK 0001346824 | Director, 10% Owner |
| Kolchinsky PeterCIK 0001384859 | Director, 10% Owner |
| Shah Rajeev M.CIK 0001619841 | Director, 10% Owner |
| RA Capital Nexus Fund II, L.P.CIK 0001825376 | Director, 10% Owner |
Non-derivative securities (Table I)
Acquisitions and disposals of common stock and similar shares, one row per line on the filing.
| Trade date | Security | Transaction | Shares | Price | Value | Shares after | Ownership | Flags |
|---|---|---|---|---|---|---|---|---|
| Mar 23, 2023 | Common Stock | PPurchaseAcquired | +155,089 | $26.67 | +$4,136,223.63 | 6,217,593 | Indirect | |
| Mar 24, 2023 | Common Stock | PPurchaseAcquired | +192,335 | $26.87 | +$5,168,041.45 | 6,409,928 | Indirect | |
| Mar 27, 2023 | Common Stock | PPurchaseAcquired | +151,132 | $27.48 | +$4,153,107.36 | 6,561,060 | Indirect |
Footnotes
Livermore does not store Form 4 footnotes. For price ranges, how indirect holdings are held and trading plan details, read the original on SEC EDGAR.